Examining the relationship between psychotropic medication use and testing positive for Chlamydia and Gonorrhea among detained adolescents

ObjectiveWe examined whether psychotropic medication (PTM) use was related to testing positive for Chlamydia and Gonorrhea among detained adolescents.MethodsA convenience sample of 550 detained adolescents ages 14–18 years were recruited from eight youth detention centers in Georgia. Using A-CASI technology, data was collected on demographic factors, use of PTM, and sexual risk behaviors. Chlamydia and Gonorrhea diagnoses were assessed by laboratory testing.ResultsThirteen percent (13.1%) of adolescents not using PTMs tested positive for STIs compared to only 4.9% of those reporting PTM use. PTM users had a 62% smaller odds ratio for testing positive for Chlamydia or Gonorrhea.ConclusionFindings suggest that use of psychotropic medication, if deemed useful by detained youth, may be a protective factor against engaging in behaviors which may culminate in contracting some STDs. The practice implications are discussed within the context of these findings.

Research highlights
► 4.9% PTM users compared to 13.1% PTM non users reported STIs.
► PTM users had a 62% smaller odds ratio for testing STI positive.
► PTM may offer some protection against STI-related.